Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
BCRX
$7.61
-0.91%
BCRX
· Biocryst Pharmaceuticals Inc
$7.61
-0.07 (-0.91%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.96B
Shares
257.30M
Volume · Nov 13
2.32M
Avg daily vol (3M)
4.87M
All webcasts
Earnings call · FY2019 Q4
Biocryst Pharmaceuticals Inc (BCRX) Q4 2019 Earnings Call
Revenue
$39.73M
+1355.7% YoY
Gross margin · derived Q4
94.1%
Net income
-$2.62M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 5, 2020 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 13, 2020 · complete as-filed document